Financials data is unavailable for this security.
View more
Year on year Windtree Therapeutics Inc had revenues remain flat at 0.00, though the company grew net income from a loss of 39.21m to a smaller loss of 20.29m.
Gross margin | -- |
---|---|
Net profit margin | -- |
Operating margin | -- |
Return on assets | -32.86% |
---|---|
Return on equity | -150.80% |
Return on investment | -40.15% |
More ▼
Cash flow in USDView more
In 2023, cash reserves at Windtree Therapeutics Inc fell by 1.86m. Cash Flow from Financing totalled 11.60m or -- of revenues. In addition the company used 13.44m for operations while cash used for investing totalled 15.00k.
Cash flow per share | -3.90 |
---|---|
Price/Cash flow per share | -- |
Book value per share | 17.65 |
---|---|
Tangible book value per share | -25.01 |
More ▼
Balance sheet in USDView more
Current ratio | 0.2346 |
---|---|
Quick ratio | -- |
Total debt/total equity | 0.1922 |
---|---|
Total debt/total capital | 0.1612 |
More ▼